Beckman Coulter Life Sciences leading the way to help labs comply with confidence for upcoming annex 1 regulation deadline

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues its relentless commitment to providing laboratories of all sizes with individualized and tailored support to meet the evolving list of regional and global compliance requirements.

Beckman Coulter Life Sciences leading the way to help labs comply with confidence for upcoming annex 1 regulation deadline

Image Credit: Beckman Coulter Life Sciences

Cleanroom laboratories manufacturing sterile medicinal products in the European Union (EU) must make critical changes by August 25, 2023 to ensure Annex 1 Regulation compliance. This is a substantial update to the initial version released in 2008 and provides comprehensive guidance for manufacturers, including the design and control of facilities, equipment, systems, and procedures used for the manufacture of all sterile products to ensure that microbial, particulate, and endotoxin/pyrogen contamination is prevented.

At 58 pages and 293 paragraphs, we understand laboratory professionals have questions about this updated and broad regulation. This new era of compliance will raise questions, and we are committed to working with laboratories of all sizes to clarify and provide answers to complex questions as we continue to lead the way in providing resources and consultations for laboratories to ensure a seamless compliance transition.”

Anurag Tandon, Global Vice President, Quality Control and BioManufacturing, Beckman Coulter Life Sciences

Key focus areas in the revised regulation include applying the principles of Quality Risk Management (QRM), ensuring continuous environmental monitoring, online total organic carbon (TOC) monitoring, and an increased emphasis on the importance of having a robust Contamination Control Strategy (CCS) in place. The classification of cleanrooms and environmental monitoring is also increasingly important throughout the update.

“Solutions from Beckman Coulter Life Sciences for analyzing total organic carbon, environmental monitoring and particle counting are used every day around the world to help ensure quality and safety in diverse applications,” Tandon continued. “We share a name with measurement principles that drive particle counting and characterization technology – The Coulter Principle – and are a trusted resource for instruments delivering critical data to researchers, formulation development scientists, and GMP regulated quality control departments around the world.”

MET ONE 3400+ Series portable air particle counters from Beckman Coulter Life Sciences enable labs to monitor air cleanliness in compliance with EU GMP Annex 1 Regulation, ISO 14644, and FDA CGMP, with features that include plug-and-play networking and customized electronic SOP maps.

Annex 1 Regulation also includes a focus on utilities, including water systems. The ANATEL PAT700 TOC analyzer is specifically designed to help demonstrate compliance to the pharmacopeial requirements for TOC and conductivity for purified water and Water for Injection (WFI) systems.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Beckman Coulter Life Sciences. (2023, July 25). Beckman Coulter Life Sciences leading the way to help labs comply with confidence for upcoming annex 1 regulation deadline. News-Medical. Retrieved on April 27, 2024 from https://www.news-medical.net/news/20230725/Beckman-Coulter-Life-Sciences-leading-the-way-to-help-labs-comply-with-confidence-for-upcoming-annex-1-regulation-deadline.aspx.

  • MLA

    Beckman Coulter Life Sciences. "Beckman Coulter Life Sciences leading the way to help labs comply with confidence for upcoming annex 1 regulation deadline". News-Medical. 27 April 2024. <https://www.news-medical.net/news/20230725/Beckman-Coulter-Life-Sciences-leading-the-way-to-help-labs-comply-with-confidence-for-upcoming-annex-1-regulation-deadline.aspx>.

  • Chicago

    Beckman Coulter Life Sciences. "Beckman Coulter Life Sciences leading the way to help labs comply with confidence for upcoming annex 1 regulation deadline". News-Medical. https://www.news-medical.net/news/20230725/Beckman-Coulter-Life-Sciences-leading-the-way-to-help-labs-comply-with-confidence-for-upcoming-annex-1-regulation-deadline.aspx. (accessed April 27, 2024).

  • Harvard

    Beckman Coulter Life Sciences. 2023. Beckman Coulter Life Sciences leading the way to help labs comply with confidence for upcoming annex 1 regulation deadline. News-Medical, viewed 27 April 2024, https://www.news-medical.net/news/20230725/Beckman-Coulter-Life-Sciences-leading-the-way-to-help-labs-comply-with-confidence-for-upcoming-annex-1-regulation-deadline.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Beckman Coulter Life Sciences launches Cytobank v10 platform